ESNT Essent (ESNT) Insider Trading, Ownership & Congress Trades
Insurance · Surety insurance · CIK 0001448893
Form 144 · 6
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
178
13F, latest reported quarter
Conversions, 180 days
16
Codes C/M, not in net · $0 priced
What the filings say about ESNT
Insiders, 180 days
-$14.5M net sold
6 sellers · 38% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-06-17
Planned sales (Form 144), 90 days
$8.5M
6 notices
Essent insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Essent Group Ltd. insiders sold a net $14.5M of stock across 67 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Jun 26, 2026.
- The trade is 18.3% of the 29,994 shares held after it.
- 4 other insiders sold within 30 days.
- 178 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP and CFO WEINSTOCK DAVID B sold about $377.0K of ESNT under a 10b5-1 plan on Sep 15, 2026; 4 other insiders sold within 30 days and 178 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Nov 14, 2025.
- The trade is 9.8% of the 23,861 shares held after it.
- 4 other insiders sold within 30 days.
- 178 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director KASMAR ROY JAMES sold about $160.6K of ESNT under a 10b5-1 plan on Sep 14, 2026; 4 other insiders sold within 30 days and 178 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Nov 14, 2025.
- The trade is 11.7% of the 21,361 shares held after it.
- 4 other insiders sold within 30 days.
- 178 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director KASMAR ROY JAMES sold about $171.8K of ESNT under a 10b5-1 plan on Sep 14, 2026; 4 other insiders sold within 30 days and 178 funds added in the latest 13F quarter.Context
- 9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Aug 19, 2026.
- The trade is 0.0% of the 2,038,893 shares held after it.
- 4 other insiders sold within 30 days.
- 178 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman, CEO and President CASALE MARK sold about $55.9K of ESNT under a 10b5-1 plan on Sep 3, 2026; 4 other insiders sold within 30 days and 178 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on May 13, 2025.
- The trade is 8.3% of the 30,154 shares held after it.
- 4 other insiders sold within 30 days.
- 178 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director PAULS DOUGLAS J sold about $174.2K of ESNT on Aug 24, 2026; 4 other insiders sold within 30 days and 178 funds added in the latest 13F quarter.67 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$14.5M over 180 days
-$4.9M over 90 days
below 80% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
178 funds bought in last quarter
more than 58% of Insurance
Revenue
+1.5% year over year
below 75% of Insurance
Margin
54.7% net margin
more than 92% of Insurance
Buybacks
$362.7M repurchased, FY to 2026-06-30
more than 68% of Insurance
Short interest
4.4% of the float short (float per yahoo 2026-10-27) · 4.8 days to cover · settled 2026-10-15
more than 73% of Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch ESNT
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+10.6%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns ESNT: institutional holders (13F)
13F holdings, latest reported quarter
12,427,447 sh
$798.8M
7,579,062 sh
$487.2M
5,415,221 sh
$348.1M
4,538,937 sh
$291.8M
3,990,051 sh
$256.5M
Congress trades in ESNT
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-06-17 · disclosed 57 days later
$1,001 - $15,000
Bought 2025-06-11 · disclosed 63 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
ESNT planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
KASMAR ROY JAMES
Filed 2026-09-14
$160.6K
KASMAR ROY JAMES
Filed 2026-09-14
$171.6K
PAULS DOUGLAS J
Filed 2026-08-24
$171.6K
Bhasin Vijay
Filed 2026-08-18
$992.2K
Mark Casale
Filed 2026-08-18
$6.9M
ESNT mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
ALPS | OShares U.S. Small-Cap Quality Dividend ETF
$15.9M position · as of 2026-05-31
1.8%
VELA SMALL CAP FUND
$2.3M position · as of 2026-06-30
1.2%
Invesco S&P MidCap Low Volatility ETF
$8.2M position · as of 2026-05-31
1.1%
Victory Integrity Small-Cap Value Fund
$12.8M position · as of 2026-06-30
1.1%
Clearwater Select Equity Fund
$5.1M position · as of 2026-06-30
1.0%
Empower Small Cap Growth Fund
$2.3M position · as of 2026-06-30
0.9%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mark A. Casale
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$8.9M
$20.1M
$2.4M
+26%
+102%
2022
$8.9M
$6.2M
$2.7M
-13%
+63%
2021
$9.1M
$6.2M
$2.6M
-4%
+15%
2020
$6.8M
$3.9M
$1.7M
-13%
-14%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $14.5M sold by insiders over 180 days, 178 funds added last quarter, $8.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
ESNT financials
Revenue growth
+1.5%
XBRL, annual
Net margin
54.7%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.3B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ESNT
| FY Dec 2025 | $1.3B |
| FY Dec 2024 | $1.2B |
| FY Dec 2023 | $1.1B |
| FY Dec 2022 | $1.0B |
| FY Dec 2021 | $1.0B |
| Jun 2026 | $362.7M |
| Mar 2026 | $336.1M |
| Dec 2025 | $312.4M |
| Sep 2025 | $311.8M |
| Jun 2025 | $319.1M |
| Mar 2025 | $317.6M |
| Dec 2024 | $315.0M |
| Sep 2024 | $316.6M |
At each fiscal year end
Single quarter
Net margin, TTM
+51.5%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM ESNT
| FY Dec 2025 | +54.7% |
| FY Dec 2024 | +58.7% |
| FY Dec 2023 | +62.8% |
| FY Dec 2022 | +83.1% |
| FY Dec 2021 | +66.3% |
| Jun 2026 | +52.3% |
| Mar 2026 | +51.1% |
| Dec 2025 | +49.6% |
| Sep 2025 | +52.7% |
| Jun 2025 | +61.2% |
| Mar 2025 | +55.2% |
| Dec 2024 | +53.3% |
| Sep 2024 | +55.6% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$825.9M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM ESNT
| FY Dec 2025 | $848.7M |
| FY Dec 2024 | $854.8M |
| FY Dec 2023 | $759.0M |
| FY Dec 2022 | $584.8M |
| FY Dec 2021 | $706.8M |
| Jun 2026 | $196.1M |
| Mar 2026 | $191.2M |
| Dec 2025 | $228.0M |
| Sep 2025 | $210.6M |
| Jun 2025 | $188.8M |
| Mar 2025 | $221.3M |
| Dec 2024 | $226.0M |
| Sep 2024 | $228.7M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity ESNT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt ESNT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity ESNT
| FY Dec 2025 | +12.1% |
| FY Dec 2024 | +13.6% |
| FY Dec 2023 | +14.6% |
| FY Dec 2022 | +19.1% |
| FY Dec 2021 | +16.8% |
| Jun 2026 | +12.0% |
| Mar 2026 | +12.1% |
| Dec 2025 | +12.1% |
| Sep 2025 | +12.4% |
| Jun 2025 | +12.9% |
| Mar 2025 | +13.3% |
| Dec 2024 | +13.6% |
| Sep 2024 | +14.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+9.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ESNT
| FY Dec 2025 | +9.5% |
| FY Dec 2024 | +10.8% |
| FY Dec 2023 | +11.5% |
| FY Dec 2022 | +14.5% |
| FY Dec 2021 | +12.5% |
| Jun 2026 | +9.2% |
| Mar 2026 | +9.3% |
| Dec 2025 | +9.5% |
| Sep 2025 | +9.7% |
| Jun 2025 | +10.3% |
| Mar 2025 | +10.5% |
| Dec 2024 | +10.8% |
| Sep 2024 | +11.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital ESNT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed ESNT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
9.29x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing ESNT
| FY Dec 2025 | 9.42x |
| FY Dec 2024 | 7.95x |
| FY Dec 2023 | 8.11x |
| FY Dec 2022 | 5.04x |
| FY Dec 2021 | 7.45x |
| Jun 2026 | 8.95x |
| Mar 2026 | 8.31x |
| Dec 2025 | 9.42x |
| Sep 2025 | 9.24x |
| Jun 2025 | 8.85x |
| Mar 2025 | 8.44x |
| Dec 2024 | 7.95x |
| Sep 2024 | 9.32x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value ESNT
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+13.8%
TTM free cash flow over market value at close 2026-10-26
FCF yield ESNT
| FY Dec 2025 | +13.5% |
| FY Dec 2024 | +14.8% |
| FY Dec 2023 | +13.5% |
| FY Dec 2022 | +14.0% |
| FY Dec 2021 | +14.1% |
| Jun 2026 | +13.9% |
| Mar 2026 | +14.8% |
| Dec 2025 | +13.5% |
| Sep 2025 | +13.5% |
| Jun 2025 | +14.0% |
| Mar 2025 | +14.4% |
| Dec 2024 | +14.8% |
| Sep 2024 | +12.3% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.99x
P/E over trailing EPS growth of 5%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing ESNT
| FY Dec 2025 | 12.91x |
| FY Dec 2024 | 1.48x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 0.19x |
| FY Dec 2021 | 0.13x |
| Jun 2026 | 1.92x |
| Mar 2026 | 2.99x |
| Dec 2025 | 12.91x |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | 2.43x |
| Dec 2024 | 1.48x |
| Sep 2024 | 0.87x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $1.1B | $1.0B |
| Net income | $690.0M | $729.4M | $696.4M | $831.4M |
| EPS (diluted) | 6.90 | 6.85 | 6.50 | 7.72 |
| Operating cash flow | $856.1M | $861.5M | $763.0M | $588.8M |
| Buybacks | $587.7M | $111.5M | $70.7M | $97.9M |
| Dividends paid | $122.1M | $118.0M | $106.2M | $92.1M |
SEC XBRL, fiscal years, as known on 2026-10-28
ESNT Stock Sonar score 5/7 axes
Find similar shapesCompareESNT ranks highest on profitability (65th percentile) and risk and compliance (65th), and lowest on insider conviction (11th), among Insurance peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ESNT filings, in plain words
Are Essent insiders buying or selling ESNT?
In the 180 days to 2026-10-28, Essent insiders were net sellers, a net $14.5M across purchases and sales reported on Form 4, by 6 sellers.
Have members of Congress traded ESNT?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Lisa McClain dated 2025-06-17.
Are there planned insider sales of ESNT?
Yes. 6 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $8.5M of stock; the latest, by KASMAR ROY JAMES, was filed 2026-09-14.
Read the full summary
In the 180 days to 2026-10-28, Essent insiders were net sellers of ESNT, a net $14.5M across purchases and sales reported on Form 4 by 6 sellers. 38% of the 16 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Members of Congress have disclosed trades in ESNT, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-06-17. Insiders filed 6 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $8.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
